{"id":"palliative-care-group-first-line-scheme","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a first-line palliative care scheme rather than a single-entity drug, designed to address pain, symptom burden, and functional decline in patients with advanced or terminal illness. It likely integrates Chinese herbal medicine formulations with conventional supportive care, focusing on symptom management and comfort rather than curative intent.","oneSentence":"A palliative care regimen combining traditional Chinese medicine and supportive care approaches to manage symptoms and improve quality of life in advanced disease.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:59:36.792Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Palliative symptom management in advanced cancer"},{"name":"Quality of life improvement in terminal illness"}]},"trialDetails":[{"nctId":"NCT05894694","phase":"PHASE4","title":"Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer","status":"RECRUITING","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2023-09-27","conditions":"Advanced Colorectal Carcinoma","enrollment":320}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"palliative care group first-line scheme","genericName":"palliative care group first-line scheme","companyName":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","companyId":"guang-anmen-hospital-of-china-academy-of-chinese-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A palliative care regimen combining traditional Chinese medicine and supportive care approaches to manage symptoms and improve quality of life in advanced disease. Used for Palliative symptom management in advanced cancer, Quality of life improvement in terminal illness.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}